Antifungal Drugs Market Projected To Reach USD 19.16 Billion By 2030 Amid Rising Incidence Of Fungal Infections - Global Research 2024

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Anti Fungal Drugs - market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
In a comprehensive analysis, experts forecast the Antifungal Drugs Market to expand at a robust CAGR, with a projected market value of USD 19.16 billion by the year 2030. This significant growth is primarily propelled by the mounting incidence rates of various fungal infections worldwide and advancements in antifungal drug research and development.
Fungal Infections on the Rise
Current data underscores an alarming increase in the prevalence of fungal infections, sparking greater demand for effective therapeutics. With the frequency of nosocomial, or hospital-acquired infections climbing-particularly in intensive care units across various regions-the requirement for antifungal agents has intensified. This surge is anticipated to play a pivotal role in augmenting the market through to 2030.
Innovation Fuels Market Expansion
The industry is witnessing a remarkable tide of innovation, marked by new drug developments and a wave of over-the-counter antifungal medications. Industry leaders continue to advance clinically superior and cost-effective solutions, reducing overall therapy expenses, enhancing patient adherence, and minimizing required physician intervention. These key market progressions are slated to unlock further growth avenues for the antifungal drugs market.
Prevalence of Azoles Bolsters Market Segment
Azoles, a category of antifungal drugs, are anticipated to make a significant revenue impact in 2023, drawing upon their broad application scope and compliance with safety standards. Their reduced side effect profile and better pharmacokinetic properties contribute to their competitive market edge. As players introduce new formulations and pursue FDA approvals, the azoles segment of the antifungal drugs market is geared for striking growth through the assessment period.
North America to Dominate Market
North America retains a dominant hold over the market, a trend forecasted to continue into the 2030 horizon. The pivotal drivers for this region include heightened awareness of antifungal treatments, the emergence of OTC options, and the persistent efforts of domestic industry giants. As the region confronts a growing number of fungal infection cases, the alignment of market forces in North America is likely to underpin its sustained market supremacy.
Key Players Leading the Market
The market landscape boasts the presence of several eminent players operating with a shared objective to address the urgent therapeutic needs sparked by the rise of fungal infections. These companies are not only fortifying existing portfolios but are also seamlessly integrating innovative strategies to create and market antifungal drugs that meet the evolving demands and regulatory standards seamlessly.
The in-depth market analysis reflects the profound impact of these overarching trends and strategic corporate operations on shaping the future trajectory of the Antifungal Drugs Market. The industry stands at the cusp of transformational growth driven by technological advancements, increased incidence of fungal infections, and an unyielding commitment to enhancing patient outcomes.
A selection of companies mentioned in this report includes, but is not limited to:

• Abbott Bayer AG
• GSK plc
• Merck & Co., Inc
• Cadila Pharmaceuticals
• Glenmark
• SCYNEXIS, Inc
• Astellas Pharma d.o.o
• Arcadia Consumer Healthcare
• Novartis AG
• Pfizer Inc
• Leadiant Biosciences, Inc
• Sun Pharmaceutical Industries Ltd
• Viatris Inc
• Sanofi
• Gilead Sciences, Inc
• Apotex Inc
• Aurobindo Pharma USA
• Cipla Inc
• Dr. Reddy's Laboratories Ltd

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN01112024004107003653ID1108841936